Opendata, web and dolomites
H2020 projects about "influenza"
The page lists 54 projects related to the topic "influenza".
| # | |||
|---|---|---|---|
| 1 | I-MOVE-plus | I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly | 2015 |
| 2 | Disasters | Market Beliefs and Optimal Policy in the Presence of Disasters | 2015 |
| 3 | ANTIVIRALS | European Training Network on Antiviral Drug Development | 2015 |
| 4 | MEMBRANEFUSION | Structure and mechanism of viral and cellular membrane fusion machineries | 2015 |
| 5 | HistoricEpi | Quantiative Study of Major Historic Epidemics and Transitions to longer, healthier lives | 2015 |
| 6 | HAAIV | Adaptive evolutionary pathways of highly pathogenic avian H5N1 influenza in humans | 2015 |
| 7 | REACTION | Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans | 2014 |
| 8 | GV-FLU | A Genetic View of Influenza Infection | 2015 |
| 9 | ERVE | Systematic discovery of functional elements in RNA virus genomes: an Encyclopedia of RNA Virus Elements | 2015 |
| 10 | BROADimmune | Structural, genetic and functional analyses of broadly neutralizing antibodies against human pathogens | 2015 |
| 11 | SWEETOOLS | Smart Biologics: Developing New Tools in Glycobiology | 2016 |
| 12 | FLUSENSOR | FLUSENSOR - innovative, ultra-sensitive, fast and cheap micro-test to detect influenza virus | 2016 |
| 13 | PHA-ST-TRAIN-VAC | Leveraging Pharmaceutical Sciences and Structural Biology Training to develop 21st Century Vaccines | 2016 |
| 14 | MIMESIS | A novel systems biology approach to develop preclinical assets from innovative drug discovery starting points inspired by viruses | 2016 |
| 15 | H-CCAT | Solid Catalysts for activation of aromatic C-H bonds | 2017 |
| 16 | VACCELERAID | A novel vaccine technology leading to accelerated availability of vaccines and improved delivery | 2016 |
| 17 | CARBOFLU | Chemoenzymatic synthesis of complex glycans to decipher the interactions between them and Influenza A virus | 2017 |
| 18 | AcTaferon | Revitalizing the clinical potential of type I IFNs in fighting influenza A virus infections with AcTaferon. | 2017 |
| 19 | IAV-m6A | Elucidating the role of m6A RNA methylation on the replication and pathogenesis of influenza A virus. | 2017 |
| 20 | DELTA-FLU | Dynamics of avian influenza in a changing world | 2017 |
| 21 | DRIVE | Development of Robust and Innovative Vaccine Effectiveness | 2017 |
| 22 | VIVALDI | Veterinary Validation of Point-of-Care Detection Instrument | 2018 |
| 23 | ANTIViR | Molecular mechanisms of interferon-induced antiviral restriction and signalling | 2017 |
| 24 | HIV B Cell Function | Understanding HIV-specific B cell function and viral immunogenicity | 2018 |
| 25 | Za-AV | Determination of physiologically relevant RNA substrate(s) and design of small-molecule inhibitors for Zα domains as potential intervention strategies for viral infections and autoimmunity | 2018 |
| 26 | TC-Evo | Molecular and functional evolution of human CD8+ T cell repertoires | 2018 |
| 27 | rSAMs-NANO | Nanoparticles with switchable shells for virus sensing and inhibition | 2018 |
| 28 | AvINFLUENZA | Molecular basis of avian influenza polymerase adaptation to human hosts | 2019 |
| 29 | FluPRINT | Tracing the inFLUenza vaccine imPRINT on immune system to identify cellular signature of protection | 2018 |
| 30 | MIDIDP | Modeling Infectious Diseases in Dynamic Populations with Relocation and Refugeeism | 2018 |
| 31 | SIGNIA | SIGNIA: An innovative drug discovery platform for rapid identification and validation of antimicrobial applications in available pharmaceutical resources and drugs open for repurposing. | 2018 |
| 32 | UNIFLUVAC | A novel universal influenza vaccine targeting epitopes of limited variability | 2018 |
| 33 | FIT2GO | A toolbox for fitness landscapes in evolution | 2019 |
| 34 | Sugar-Enable | Influenza Virus - Sugar Interactions, From Glycan Arrays To Better Vaccines | 2018 |
| 35 | DEVORHBIOSHIP | The Developmental Origins of Health: Biology, Shocks, Investments, and Policies | 2019 |
| 36 | LUNG-BIM | Induction of B cell immunity in the lung mucosa | 2019 |
| 37 | DIS2 | Disability and Disease during the 1918 Influenza Pandemic: Implications for Preparedness Policies | 2019 |
| 38 | DIGDEEP | Digging deeper into genes to track infectious disease outbreaks | 2020 |
| 39 | SENTIMOUV | Spatial and demographic dynamics of disease transfer at the wildlife-human interface | 2020 |
| 40 | NaviFlu | Navigating the evolutionary routes of influenza viruses | 2019 |
| 41 | FreeATPOC | Towards an instrument-free future of molecular diagnostics at the point-of-care | 2020 |
| 42 | ICRAD | INTERNATIONAL COORDINATION OF RESEARCH ON INFECTIOUS ANIMAL DISEASES | 2019 |
| 43 | B-DOMINANCE | B Cell Immunodominance in Antiviral Immunity | 2019 |
| 44 | VIVA | Vaccine development against variable pathogens | 2020 |
| 45 | MappingAir | Mapping air quality with high accuracy and high-spatial resolution | 2019 |
| 46 | HDM-FUN | Host directed medicine in invasive fungal infection | 2020 |
| 47 | CHUbVi | Ubiquitin Chains in Viral Infections | 2020 |
| 48 | ISOLDA | Improved Vaccination Strategies for Older Adults | 2020 |
| 49 | INDIGO | Effective and Affordable Flu Vaccines for the World | 2020 |
| 50 | ENDFLU | Evaluation of ratioNally Designed Influenza vaccines | 2020 |
| 51 | INCENTIVE | Indo-European Consortium for Next Generation Influenza Vaccine Innovation | 2020 |
| 52 | NANOVR | Nanoscale Design using Virtual Reality | 2020 |
| 53 | FluAttack | Validation of a novel antiviral drug candidate against influenza | 2020 |
| 54 | SupraRNA | A Comprehensive Supramolecular Approach for an RNA vaccine for Influenza A (H1N1) | 2020 |